Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer

Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase

A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.

Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence

[The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer – 229 clinical cases]

Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial

Ovarian cancer biology and immunotherapy

Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer